Se habla español
Glaucoma is a group of eye conditions that damage the optic nerve, the vital connection that carries visual signals from the eye to the brain. Damage usually occurs gradually and may not be noticeable until significant vision loss has already happened. Because the process is often painless and symptom-free in the early stages, glaucoma is frequently discovered during routine eye care rather than after a patient reports a problem.
The pattern of vision loss in glaucoma typically begins at the edges of the visual field and progresses inward, so people may not notice changes until central vision is affected. This peripheral-first progression means that screening and early detection are critical for preserving useful sight. While some forms of glaucoma progress slowly over many years, others can advance more quickly and require urgent attention.
Although there is no definitive cure for most types of glaucoma at present, modern care focuses on preventing or slowing further optic nerve injury. With timely diagnosis and appropriate management, many people retain excellent functional vision for decades. The goal of treatment is to preserve independence and quality of life by protecting remaining vision.
Glaucoma can affect adults of all ages, but certain factors increase the likelihood of developing the disease. Age is a major risk: older adults are more susceptible, and risk rises steadily after middle age. Family history also plays an important role — having a close relative with glaucoma significantly raises your own risk, which is why relatives of affected individuals should be screened regularly.
Other contributors include certain medical conditions, such as diabetes and cardiovascular disease, as well as long-term use of corticosteroid medications. People of specific ethnic backgrounds can face higher incidence of particular glaucoma subtypes; for example, some populations have a greater risk of open-angle glaucoma while others are more prone to angle-closure forms. Prior eye injury, high myopia (nearsightedness), and a history of eye surgery can also affect risk.
Because early glaucoma often lacks symptoms, vigilance matters. Regular comprehensive eye examinations that include glaucoma screening are the most reliable way to detect disease before irreversible vision loss occurs. If you have any of the risk factors described above, discuss a tailored screening schedule with your eye care provider.
A thorough glaucoma evaluation combines several tests to assess structure and function. Tonometry measures intraocular pressure (IOP), which is a key modifiable risk factor: elevated pressure increases the likelihood of optic nerve damage, though glaucoma can occur even at normal pressures. An optic nerve exam looks for characteristic structural changes, and imaging technologies such as optical coherence tomography (OCT) provide precise, reproducible measurements of nerve fiber thickness and optic nerve anatomy.
Functional testing complements these structural assessments. Visual field testing maps the patient’s peripheral vision to detect blind spots that correspond to nerve damage. Repeating visual fields over time helps clinicians determine whether the disease is stable or progressing. Your doctor will interpret these results together with imaging and pressure measurements to form a complete picture of disease status.
Additional evaluations may include pachymetry (measuring corneal thickness), gonioscopy (examining the drainage angle of the eye), and careful review of medical history and medications. Together, these tests guide personalized recommendations, balancing the risks and benefits of available treatment options and setting measurable goals for preserving vision.
Treatment for glaucoma is tailored to the individual and focuses on reducing the risk of further optic nerve damage. The most common approach aims to lower intraocular pressure, because lowering pressure has been shown to decrease the likelihood of progression. Initial therapy often involves topical medications that reduce fluid production or improve fluid outflow from the eye.
When eye drops are insufficient or not well tolerated, minimally invasive procedures and laser therapies can be effective next steps. These options are designed to either enhance the eye’s drainage pathways or decrease fluid production, and they can reduce reliance on daily medications for some patients. In more advanced or rapidly progressing cases, traditional surgery may be recommended to provide a larger, sustained pressure reduction.
Choosing the right therapy involves weighing the severity of disease, rate of progression, coexisting health conditions, and patient preferences. Regular follow-up exams and testing let clinicians track response to treatment and adjust plans as needed. Open communication with your care team about how treatments are working — including side effects or challenges with administration — helps achieve the best long-term outcomes.
At Next Level Retina, our approach centers on individualized care: we combine detailed diagnostic information with practical treatment plans to protect vision while minimizing lifestyle disruption. Collaboration between you and your eye specialist is essential to maintain stability and respond promptly if disease activity changes.
Living well with glaucoma means staying engaged with ongoing monitoring and making small, sustainable adjustments in daily life. Adherence to prescribed treatments is one of the strongest predictors of favorable outcomes. If you have difficulty using eye drops — because of scheduling, physical limitations, or side effects — discuss alternatives with your clinician so a workable plan can be established.
Routine follow-up appointments are essential. These visits typically include pressure checks, imaging, and visual field testing at intervals determined by disease severity and stability. Keeping a personal record of test dates and results can help you track trends and participate actively in care decisions. Promptly reporting any new visual changes, eye pain, or sudden symptoms ensures timely evaluation.
Simple lifestyle measures may also support overall eye health: controlling systemic conditions like diabetes and high blood pressure, avoiding tobacco, protecting the eyes from injury, and maintaining a balanced diet and regular exercise routine. While these actions do not replace glaucoma-directed therapy, they contribute to overall wellness and vision preservation.
Education and clear communication are important sources of support. Understanding what the tests mean, why treatment targets are set at specific levels, and what to expect from follow-up care helps reduce uncertainty and empowers patients to take an active role in protecting their vision.
Summary and next steps: if you are concerned about glaucoma or have been told you are at risk, early evaluation and consistent follow-up provide the best chance to preserve vision. Next Level Retina and Dr. Lamba offer comprehensive diagnostic testing and individualized treatment planning to keep your optic nerve healthy and your vision stable. Contact us to learn more about our glaucoma services and to schedule an evaluation tailored to your needs.
Glaucoma is a group of eye conditions that injure the optic nerve, the pathway that transmits visual information from the eye to the brain. The damage most often develops slowly and without pain, so many people have no noticeable symptoms until vision loss has already occurred. Early injury typically affects peripheral vision first, making routine screening essential to catch disease before central vision is involved.
The primary goal of care is to prevent or slow further optic nerve damage and preserve functional vision. Clinicians combine pressure measurements, structural imaging and visual field tests to determine disease status and risk of progression. With timely diagnosis and appropriate management, many people maintain useful vision for many years.
Several factors increase glaucoma risk, including older age, a family history of the disease, certain ethnic backgrounds, and a personal history of eye injury or surgery. Medical conditions such as diabetes and cardiovascular disease and prolonged use of corticosteroid medications also raise risk. High myopia and thin corneas can further influence an individual’s susceptibility and the interpretation of pressure measurements.
Because early glaucoma is often symptomless, people with these risk factors should discuss a tailored screening schedule with their eye care provider. Screening frequency depends on age, medical history and baseline test results, and may be coordinated between an optometrist, general ophthalmologist and subspecialist when needed. Family members of patients with glaucoma should consider regular exams to detect disease at an early, treatable stage.
Diagnosis relies on a combination of structural and functional tests that together assess optic nerve health and visual function. Common evaluations include tonometry to measure intraocular pressure, optical coherence tomography (OCT) to quantify nerve fiber thickness, and automated visual field testing to map peripheral vision. Additional tests such as pachymetry to measure corneal thickness and gonioscopy to examine the drainage angle help classify glaucoma type and guide management.
Clinicians interpret these measurements over time to determine whether disease is stable or progressing and to set individualized treatment targets. Baseline testing creates a reference for future comparison, and repeat exams at scheduled intervals reveal trends that inform therapeutic changes. Clear communication of results helps patients understand their condition and engage in shared decision-making about care.
Treatment is individualized and centers on lowering intraocular pressure to reduce the risk of further optic nerve damage. First-line therapy often includes topical medications that decrease fluid production or improve outflow, and many patients achieve stability with drops alone. When medications are insufficient or not tolerated, laser procedures and minimally invasive glaucoma surgeries can lower pressure while reducing dependence on daily medications.
More advanced or rapidly progressive disease may require traditional filtering surgery to achieve a larger, sustained pressure reduction. Selecting the right option takes into account disease severity, rate of progression, coexisting eye conditions and patient lifestyle. Ongoing monitoring after any treatment ensures effectiveness and guides additional steps if disease activity changes.
Consistent adherence to prescribed treatments is one of the most important factors in preserving vision with glaucoma. Learn proper eye drop technique, establish a schedule that fits your daily routine, and report side effects or administration difficulties to your clinician so alternatives can be considered. Keeping a personal record of test dates and results helps you and your provider track stability over time.
Lifestyle and health measures support overall eye health but do not replace glaucoma-directed therapy; controlling systemic conditions like diabetes and high blood pressure, avoiding tobacco and protecting the eyes from injury are all beneficial. If you have difficulty using drops, ask about alternative delivery options such as sustained-release implants or procedures that may reduce medication burden. Promptly report new visual changes, eye pain or sudden symptoms to ensure timely evaluation.
Most forms of glaucoma are not curable, but early detection and appropriate treatment can slow or halt progression and preserve meaningful vision. The emphasis of modern care is on lowering intraocular pressure to reduce the risk of further optic nerve injury, and many patients remain stable for years with proper management. Preventive strategies focus on identifying disease early in at-risk individuals rather than eliminating glaucoma entirely.
Ongoing research explores neuroprotective therapies and new surgical and drug-delivery techniques, but these approaches are still under investigation and are not yet definitive cures. Family members of people with glaucoma should undergo regular eye exams, and anyone with risk factors should work with their eye care provider to establish an individualized surveillance plan. Early action provides the best chance to protect sight.
Screening and follow-up intervals depend on age, risk factors and disease status; there is no one-size-fits-all schedule. Adults with no risk factors often begin regular comprehensive eye exams around age 40, while those with elevated risk or suspicious findings may need annual or more frequent testing. Patients with confirmed glaucoma typically follow a schedule determined by disease severity and stability, which can range from a few months to a year between visits.
Follow-up visits usually include pressure checks, imaging and visual field testing at intervals that allow clinicians to detect progression early. Adherence to the recommended schedule is essential because timely changes in therapy can prevent irreversible vision loss. Discuss any scheduling questions with your provider to ensure monitoring matches your individual needs.
Acute angle-closure glaucoma presents suddenly and is an ocular emergency; typical symptoms include severe eye pain, headache, nausea, vomiting, a red eye and a sudden decrease in vision often accompanied by halos around lights. The affected eye may feel hard to the touch and the pupil can appear mid-dilated and sluggish. Because this form of glaucoma can cause rapid and irreversible optic nerve damage, immediate evaluation and treatment are critical.
Treatment in the acute setting focuses on rapidly lowering intraocular pressure and relieving the angle closure, often using a combination of medications and urgent laser or surgical procedures such as laser peripheral iridotomy. After the acute episode, clinicians plan definitive care and ongoing monitoring to prevent recurrence. If you experience the symptoms described, seek immediate emergency eye care.
Topical medications are commonly used as initial therapy because they can effectively lower pressure and are reversible, but they require daily adherence and may cause local or systemic side effects. Laser procedures, such as selective laser trabeculoplasty, can reduce pressure and sometimes decrease the need for drops; they are typically outpatient and repeatable. Minimally invasive glaucoma surgeries (MIGS) and traditional filtering surgeries offer progressively greater pressure-lowering potential and are considered when medications and laser are inadequate or when more substantial, sustained reduction is needed.
The choice among drops, laser and surgery balances the severity and rate of disease progression, the patient’s tolerance for medications, concurrent ocular conditions and personal preferences. Each option carries risks and benefits that should be discussed thoroughly with your clinician. Ongoing monitoring after any intervention ensures that the chosen strategy is meeting goals and allows adjustments if necessary.
Next Level Retina provides individualized glaucoma care that combines comprehensive diagnostic testing with personalized treatment planning to protect vision while minimizing lifestyle disruption. Dr. Neel Lamba and the clinical team use pressure measurement, OCT imaging and visual field testing to form a complete picture of disease status and to set clear, measurable treatment goals. Collaboration between the patient and care team guides decisions about medications, laser therapy or surgical options based on disease severity and patient priorities.
The practice emphasizes clear education and regular monitoring so patients understand what to expect and can participate actively in their care. If you are concerned about glaucoma or are at higher risk, schedule an evaluation in Oak Brook to establish a baseline and a follow-up plan tailored to your needs by calling (630) 242-5511. Prompt detection and consistent follow-up offer the best chance to preserve vision over the long term.
Phone:
Fax:
